최신자료
Strengthening the Life-Science Industry in the People’s Republic of China
It explains how the PRC’s health-care sector has largely focused on imported and low-cost generic medicines, looks at the impact of complex regulations, and outlines the government’s strategy to boost scientific development and improve health. It sets out ways to expand translational medicine systems and assesses how MDBs can help strengthen financing, incentivize innovation, and improve quality standards.
많이 본 자료
![[팀튜링의 디지털 오디세이] 제1화 UAM의 미래](/userdata/main/incContent/sideLink/19/aaaGHKBjsPPI5g31szc-y20240605110816byhta.png)
![[2024.04] 물가상승](/userdata/main/incContent/sideLink/20/aaaGHKBjsPPI5g31szc-y20240605111046bpogp.jpg)
